Philip Bath (FRCP FRCPath DSc FMedSci) is Stroke Association Professor of Stroke Medicine and Head of Academic Stroke at the University of Nottingham, an Emeritus National Institute of Health Research Senior Investigator, and consultant stroke physician at Nottingham University Hospitals NHS Trust. He was the UK Stroke Association’s Keynote Lecturer in 2015, the International Stroke Conference William M Feinberg Award Lecturer for Excellence in Clinical Stroke in 2016 and received the President’s Award for Research from the British Association of Stroke Physicians in 2019 and President’s Award from the World Stroke Organisation in 2021.

Prof. Bath’s is a clinical trialist with research interests in acute blood pressure management and antiplatelet and anticoagulant therapy, treatment of post-stroke dysphagia, and prevention of cognitive decline and vascular dementia. He has >500 publications. He was Chief Investigator of the TAIST (Lancet 2001), ENOS (Lancet 2015), STEPS (Stroke 2016), TARDIS (Lancet 2018) and RIGHT-2 (Lancet 2019) multicentre phase III randomised controlled trials and leads the ongoing PhEAST trial in post-stroke dysphagia. He coordinates international collaborations on acute stroke blood pressure management; and optimising the design and analysis of trials in acute stroke, stroke prevention, and cognition.